BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21805645)

  • 1. Synthesis and in vitro anticancer activity of ruthenium-cymene complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Savić A; Dulović M; Poljarević JM; Misirlić-Denčić S; Jovanović M; Bogdanović A; Trajković V; Sabo TJ; Grgurić-Šipka S; Marković I
    ChemMedChem; 2011 Oct; 6(10):1884-91. PubMed ID: 21805645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
    ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
    Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
    J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclohexyl analogues of ethylenediamine dipropanoic acid induce caspase-independent mitochondrial apoptosis in human leukemic cells.
    Misirlic Dencic S; Poljarevic J; Vilimanovich U; Bogdanovic A; Isakovic AJ; Kravic Stevovic T; Dulovic M; Zogovic N; Isakovic AM; Grguric-Sipka S; Bumbasirevic V; Sabo T; Trajkovic V; Markovic I
    Chem Res Toxicol; 2012 Apr; 25(4):931-9. PubMed ID: 22401584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: synthesis, characterization and in vitro antitumoral activity against chronic lymphocytic leukemia (CLL) cells.
    Vujić JM; Cvijović M; Kaluderović GN; Milovanović M; Zmejkovski BB; Volarević V; Arsenijević N; Sabo TJ; Trifunović SR
    Eur J Med Chem; 2010 Sep; 45(9):3601-6. PubMed ID: 20570025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
    Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
    Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific ligands and their complexes. Part VII. Synthesis, characterization and in vitro antitumoral activity of platinum(II) complexes with O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)pentanoic acid.
    Vujić JM; Kaluđerović GN; Milovanović M; Zmejkovski BB; Volarević V; Živić D; Đurđeviće P; Arsenijević N; Trifunović SR
    Eur J Med Chem; 2011 Sep; 46(9):4559-65. PubMed ID: 21840630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
    Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D
    Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
    Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
    J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
    Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
    J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
    Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer activity of opened arene ruthenium metalla-assemblies.
    Barry NP; Zava O; Furrer J; Dyson PJ; Therrien B
    Dalton Trans; 2010 Jun; 39(22):5272-7. PubMed ID: 20442944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukemic action of novel diamine Pt(II) halogenido complexes: Comparison of the representative novel Pt(II) with corresponding Pt(IV) complex.
    Misirlić Denčić S; Poljarević J; Isakovic AM; Marković I; Sabo TJ; Grgurić-Šipka S
    Chem Biol Drug Des; 2017 Aug; 90(2):262-271. PubMed ID: 28102932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antitumor activity, metal uptake and reactivity with ascorbic acid and BSA of some gold(III) complexes with N,N'-ethylenediamine bidentate ester ligands.
    Pantelić N; Zmejkovski BB; Kolundžija B; Crnogorac MĐ; Vujić JM; Dojčinović B; Trifunović SR; Stanojković TP; Sabo TJ; Kaluđerović GN
    J Inorg Biochem; 2017 Jul; 172():55-66. PubMed ID: 28433833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
    Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study.
    Yang Y; Guo L; Tian Z; Liu X; Gong Y; Zheng H; Ge X; Liu Z
    Chem Asian J; 2018 Oct; 13(19):2923-2933. PubMed ID: 30101417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and ROS-mediated cytotoxic action of novel (S,S)-1,3-propanediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid and corresponding esters.
    Savić A; Misirlić-Denčić S; Dulović M; Mihajlović-Lalić LE; Jovanović M; Grgurić-Šipka S; Marković I; Sabo TJ
    Bioorg Chem; 2014 Jun; 54():73-80. PubMed ID: 24836201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.
    Pantelić N; Stanojković TP; Zmejkovski BB; Sabo TJ; Kaluđerović GN
    Eur J Med Chem; 2015 Jan; 90():766-74. PubMed ID: 25528331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.